11-4955055-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_ModerateBP6_Moderate
The NM_001004748.1(OR51A2):c.659C>T(p.Thr220Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000225 in 1,334,356 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001004748.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR51A2 | NM_001004748.1 | c.659C>T | p.Thr220Ile | missense_variant | 1/1 | ENST00000380371.1 | NP_001004748.1 | |
MMP26 | NM_021801.5 | c.-144-33013G>A | intron_variant | ENST00000380390.6 | NP_068573.2 | |||
MMP26 | NM_001384608.1 | c.-152-33215G>A | intron_variant | NP_001371537.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR51A2 | ENST00000380371.1 | c.659C>T | p.Thr220Ile | missense_variant | 1/1 | NM_001004748.1 | ENSP00000369729 | P1 | ||
MMP26 | ENST00000380390.6 | c.-144-33013G>A | intron_variant | 5 | NM_021801.5 | ENSP00000369753 | P1 | |||
MMP26 | ENST00000300762.2 | c.-152-33215G>A | intron_variant | 1 | ENSP00000300762 |
Frequencies
GnomAD3 genomes Cov.: 18
GnomAD3 exomes AF: 0.00000879 AC: 2AN: 227634Hom.: 0 AF XY: 0.0000162 AC XY: 2AN XY: 123540
GnomAD4 exome AF: 0.00000225 AC: 3AN: 1334356Hom.: 0 Cov.: 35 AF XY: 0.00000301 AC XY: 2AN XY: 665412
GnomAD4 genome Cov.: 18
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 20, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at